Trial intelligence / Profile preview

[68Ga]Ga-PentixaFor PET/MR in Multiple Myeloma

NCT06871176Recruiting

Sponsor
University Health Network
Start
Apr 2025
Primary completion
Mar 2028
Countries
1
01

Overview

Open-label, single-arm trial of pentixafor in multiple myeloma (MM), sponsored by University Health Network. Primary endpoint: Diagnostic Accuracy of CXCR4-targeted [68Ga]Ga-PentixaFor PET/MR Imaging Compared to Standard of Care Imaging. Started Apr 2025; status: recruiting.

02

Drugs

pentixafor
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT06871176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06871176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call